Literature DB >> 2950233

Peripheral blood T lymphocyte subpopulations determined by monoclonal antibodies in active rheumatoid arthritis.

F Luyten, S Suykens, E M Veys, J Van Lerbeirghe, C Ackerman, H Mielants, G Verbruggen.   

Abstract

The introduction of an automated flow cytofluorograph has facilitated the detection of T lymphocyte subsets because it enables a larger number of cells to be analyzed. Many authors have reported a decrease of cytotoxic/suppressor T lymphocytes in rheumatoid arthritis (RA), in contrast to the results of other workers. We believe that the discrepancy between the various studies is due to the fact that different methods and different criteria for patient selection were used. Our study comprised a larger number of patients which makes the results suitable for statistical inference. Disease activity is clearly defined and all drugs that could alter the results were excluded. The use of a flow cytometer enhances the reliability of T lymphocyte subset determination by monoclonal antibodies (OKT series). Our study confirms the reports, which suggested that the number of suppressor/cytotoxic T lymphocytes (OKT8+ cells/mm3) is decreased in patients with active RA, resulting in a high T helper/inducer lymphocyte/T suppressor/cytotoxic lymphocyte ratio (OKT4+:OKT8+). This immune balance represents an interesting feature of the disease, since several active antirheumatic drugs share a common immunomodulatory action, which normalizes the OKT4+:OKT8+ ratio. Finally, we found a good correlation between the OKT4+ cells and OKT8+ cells in the normal control population. This observation enabled us to isolate a subgroup of active patients with RA not responding to slow acting antirheumatic drugs and characterized by a low OKT4+:OKT8+ ratio.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2950233

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Immunological indices of patients with rheumatoid arthritis after methylprednisolone pulse therapy.

Authors:  N Kapisinszky
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

2.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

3.  Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis.

Authors:  J G Hanly; D Pledger
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

4.  Phenotypes of peripheral blood T lymphocytes in rheumatoid arthritis and juvenile rheumatoid arthritis. Findings in patients with varying disease activity and clinical subgroups.

Authors:  J Thoen; O Førre
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.